Barbara G. Green
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Metabolism, Diabetes, and Cancer, Nitric Oxide and Endothelin Effects, Growth Hormone and Insulin-like Growth Factors, Eicosanoids and Hypertension Pharmacology, Glycosylation and Glycoproteins Research
Most-Cited Works
- → Mutants of human insulin-like growth factor I with reduced affinity for the type 1 insulin-like growth factor receptor(1988)107 cited
- → Serum Half-Life and Biological Activity of Mutants of Human Insulin-Like Growth Factor I which Do Not Bind to Serum Binding Proteins(1988)69 cited
- → Expression, purification and characterization of recombinant human insulin-like growth factor I in yeast(1988)50 cited
- → Structural Requirements for Human Inducible Nitric Oxide Synthase Substrates and Substrate Analogue Inhibitors(1998)49 cited
- → Substituted 2-aminopyridines as inhibitors of nitric oxide synthases(2000)47 cited
- → Evidence that the insulin-like activities of concanavalin A and insulin are mediated by a common insulin receptor-linked effector system(1981)38 cited
- → Evidence that insulin and concanavalin-A can co-bind to solubilized insulin receptors without inhibiting each other(1981)21 cited
- → Inhibition of nitric oxide synthase by benzoxazolones(1997)21 cited
- → Bicyclic amidine inhibitors of nitric oxide synthase: discovery of perhydro-iminopyrindine and perhydro-iminoquinoline as potent, orally active inhibitors of inducible nitric oxide synthase(2005)20 cited
- → Characterization of Inducible Nitric-oxide Synthase by Cytochrome P-450 Substrates and Inhibitors(1997)13 cited